| Tameru Dressie Demsie, MD | |
|
600 Hospital Dr, Monroe, NC 28112-6000 | |
| (704) 993-2240 | |
| Not Available |
| Full Name | Tameru Dressie Demsie |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 23 Years |
| Location | 600 Hospital Dr, Monroe, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891081618 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 2011-01068 (North Carolina) | Secondary |
| 207R00000X | Internal Medicine | 2011-01068 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Atrium Health Union | Monroe, NC | Hospital |
| Prisma Health Greenville Memorial Hospital | Greenville, SC | Hospital |
| St Francis-downtown | Greenville, SC | Hospital |
| Prisma Health Greer Memorial Hospital | Greer, SC | Hospital |
| Entity Name | Novant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366409492 PECOS PAC ID: 1153234893 Enrollment ID: O20031121000692 |
News Archive
Omthera Pharmaceuticals, a privately-held emerging specialty pharmaceuticals company, today announced data from its ECLIPSE trial, designed to evaluate the bioavailability of Epanova™, the Company's lead compound for the treatment of very high triglycerides, in comparison to Lovaza®, the leading prescription Omega 3.
InVitria announced the launch of ITSE Animal-Free™, a recombinant and defined cell culture media supplement that provides the ingredients essential for high performance cell culture. ITSE Animal-Free provides a solution for maximizing performance in a consistent and animal-free system. Insulin and transferrin supplements are commonly used in cell culture to reduce the amount of serum, such as fetal bovine serum (FBS), required to optimize performance.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the completion of the first surgical case using the Company's CAPRI™ Corpectomy Cage System, an expandable vertebral body replacement device that provides structural stability following a corpectomy or vertebrectomy.
Firefly BioWorks, Inc., a developer of next-generation multiplexed assays for biomarker detection, announced today the awarding of a $500K Grant from the Massachusetts Life Sciences Center.
Recognizing that heart health is one of the world's most significant public health challenges, Mars, Incorporated, in collaboration with Brigham and Women's Hospital (BWH), a teaching affiliate of Harvard Medical School, is launching a five-year landmark study to examine the role of cocoa flavanols, plant-derived bioactives from the cacao bean, in helping people maintain cardiovascular health.
› Verified 7 days ago
| Entity Name | Carolinas Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477878890 PECOS PAC ID: 3375449655 Enrollment ID: O20031219000455 |
News Archive
Omthera Pharmaceuticals, a privately-held emerging specialty pharmaceuticals company, today announced data from its ECLIPSE trial, designed to evaluate the bioavailability of Epanova™, the Company's lead compound for the treatment of very high triglycerides, in comparison to Lovaza®, the leading prescription Omega 3.
InVitria announced the launch of ITSE Animal-Free™, a recombinant and defined cell culture media supplement that provides the ingredients essential for high performance cell culture. ITSE Animal-Free provides a solution for maximizing performance in a consistent and animal-free system. Insulin and transferrin supplements are commonly used in cell culture to reduce the amount of serum, such as fetal bovine serum (FBS), required to optimize performance.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the completion of the first surgical case using the Company's CAPRI™ Corpectomy Cage System, an expandable vertebral body replacement device that provides structural stability following a corpectomy or vertebrectomy.
Firefly BioWorks, Inc., a developer of next-generation multiplexed assays for biomarker detection, announced today the awarding of a $500K Grant from the Massachusetts Life Sciences Center.
Recognizing that heart health is one of the world's most significant public health challenges, Mars, Incorporated, in collaboration with Brigham and Women's Hospital (BWH), a teaching affiliate of Harvard Medical School, is launching a five-year landmark study to examine the role of cocoa flavanols, plant-derived bioactives from the cacao bean, in helping people maintain cardiovascular health.
› Verified 7 days ago
| Entity Name | Novant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679528384 PECOS PAC ID: 1153234893 Enrollment ID: O20060828000304 |
News Archive
Omthera Pharmaceuticals, a privately-held emerging specialty pharmaceuticals company, today announced data from its ECLIPSE trial, designed to evaluate the bioavailability of Epanova™, the Company's lead compound for the treatment of very high triglycerides, in comparison to Lovaza®, the leading prescription Omega 3.
InVitria announced the launch of ITSE Animal-Free™, a recombinant and defined cell culture media supplement that provides the ingredients essential for high performance cell culture. ITSE Animal-Free provides a solution for maximizing performance in a consistent and animal-free system. Insulin and transferrin supplements are commonly used in cell culture to reduce the amount of serum, such as fetal bovine serum (FBS), required to optimize performance.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the completion of the first surgical case using the Company's CAPRI™ Corpectomy Cage System, an expandable vertebral body replacement device that provides structural stability following a corpectomy or vertebrectomy.
Firefly BioWorks, Inc., a developer of next-generation multiplexed assays for biomarker detection, announced today the awarding of a $500K Grant from the Massachusetts Life Sciences Center.
Recognizing that heart health is one of the world's most significant public health challenges, Mars, Incorporated, in collaboration with Brigham and Women's Hospital (BWH), a teaching affiliate of Harvard Medical School, is launching a five-year landmark study to examine the role of cocoa flavanols, plant-derived bioactives from the cacao bean, in helping people maintain cardiovascular health.
› Verified 7 days ago
| Entity Name | The Charlotte-mecklenburg Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669738829 PECOS PAC ID: 2961310685 Enrollment ID: O20100309000605 |
News Archive
Omthera Pharmaceuticals, a privately-held emerging specialty pharmaceuticals company, today announced data from its ECLIPSE trial, designed to evaluate the bioavailability of Epanova™, the Company's lead compound for the treatment of very high triglycerides, in comparison to Lovaza®, the leading prescription Omega 3.
InVitria announced the launch of ITSE Animal-Free™, a recombinant and defined cell culture media supplement that provides the ingredients essential for high performance cell culture. ITSE Animal-Free provides a solution for maximizing performance in a consistent and animal-free system. Insulin and transferrin supplements are commonly used in cell culture to reduce the amount of serum, such as fetal bovine serum (FBS), required to optimize performance.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the completion of the first surgical case using the Company's CAPRI™ Corpectomy Cage System, an expandable vertebral body replacement device that provides structural stability following a corpectomy or vertebrectomy.
Firefly BioWorks, Inc., a developer of next-generation multiplexed assays for biomarker detection, announced today the awarding of a $500K Grant from the Massachusetts Life Sciences Center.
Recognizing that heart health is one of the world's most significant public health challenges, Mars, Incorporated, in collaboration with Brigham and Women's Hospital (BWH), a teaching affiliate of Harvard Medical School, is launching a five-year landmark study to examine the role of cocoa flavanols, plant-derived bioactives from the cacao bean, in helping people maintain cardiovascular health.
› Verified 7 days ago
| Entity Name | Apogee Medical Group North Carolina |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043518228 PECOS PAC ID: 7719162254 Enrollment ID: O20110427000840 |
News Archive
Omthera Pharmaceuticals, a privately-held emerging specialty pharmaceuticals company, today announced data from its ECLIPSE trial, designed to evaluate the bioavailability of Epanova™, the Company's lead compound for the treatment of very high triglycerides, in comparison to Lovaza®, the leading prescription Omega 3.
InVitria announced the launch of ITSE Animal-Free™, a recombinant and defined cell culture media supplement that provides the ingredients essential for high performance cell culture. ITSE Animal-Free provides a solution for maximizing performance in a consistent and animal-free system. Insulin and transferrin supplements are commonly used in cell culture to reduce the amount of serum, such as fetal bovine serum (FBS), required to optimize performance.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the completion of the first surgical case using the Company's CAPRI™ Corpectomy Cage System, an expandable vertebral body replacement device that provides structural stability following a corpectomy or vertebrectomy.
Firefly BioWorks, Inc., a developer of next-generation multiplexed assays for biomarker detection, announced today the awarding of a $500K Grant from the Massachusetts Life Sciences Center.
Recognizing that heart health is one of the world's most significant public health challenges, Mars, Incorporated, in collaboration with Brigham and Women's Hospital (BWH), a teaching affiliate of Harvard Medical School, is launching a five-year landmark study to examine the role of cocoa flavanols, plant-derived bioactives from the cacao bean, in helping people maintain cardiovascular health.
› Verified 7 days ago
| Entity Name | Demsie Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316655251 PECOS PAC ID: 4688045248 Enrollment ID: O20230119000932 |
News Archive
Omthera Pharmaceuticals, a privately-held emerging specialty pharmaceuticals company, today announced data from its ECLIPSE trial, designed to evaluate the bioavailability of Epanova™, the Company's lead compound for the treatment of very high triglycerides, in comparison to Lovaza®, the leading prescription Omega 3.
InVitria announced the launch of ITSE Animal-Free™, a recombinant and defined cell culture media supplement that provides the ingredients essential for high performance cell culture. ITSE Animal-Free provides a solution for maximizing performance in a consistent and animal-free system. Insulin and transferrin supplements are commonly used in cell culture to reduce the amount of serum, such as fetal bovine serum (FBS), required to optimize performance.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the completion of the first surgical case using the Company's CAPRI™ Corpectomy Cage System, an expandable vertebral body replacement device that provides structural stability following a corpectomy or vertebrectomy.
Firefly BioWorks, Inc., a developer of next-generation multiplexed assays for biomarker detection, announced today the awarding of a $500K Grant from the Massachusetts Life Sciences Center.
Recognizing that heart health is one of the world's most significant public health challenges, Mars, Incorporated, in collaboration with Brigham and Women's Hospital (BWH), a teaching affiliate of Harvard Medical School, is launching a five-year landmark study to examine the role of cocoa flavanols, plant-derived bioactives from the cacao bean, in helping people maintain cardiovascular health.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tameru Dressie Demsie, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Tameru Dressie Demsie, MD 600 Hospital Dr, Monroe, NC 28112-6000 Ph: (704) 993-2240 |
News Archive
Omthera Pharmaceuticals, a privately-held emerging specialty pharmaceuticals company, today announced data from its ECLIPSE trial, designed to evaluate the bioavailability of Epanova™, the Company's lead compound for the treatment of very high triglycerides, in comparison to Lovaza®, the leading prescription Omega 3.
InVitria announced the launch of ITSE Animal-Free™, a recombinant and defined cell culture media supplement that provides the ingredients essential for high performance cell culture. ITSE Animal-Free provides a solution for maximizing performance in a consistent and animal-free system. Insulin and transferrin supplements are commonly used in cell culture to reduce the amount of serum, such as fetal bovine serum (FBS), required to optimize performance.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced the completion of the first surgical case using the Company's CAPRI™ Corpectomy Cage System, an expandable vertebral body replacement device that provides structural stability following a corpectomy or vertebrectomy.
Firefly BioWorks, Inc., a developer of next-generation multiplexed assays for biomarker detection, announced today the awarding of a $500K Grant from the Massachusetts Life Sciences Center.
Recognizing that heart health is one of the world's most significant public health challenges, Mars, Incorporated, in collaboration with Brigham and Women's Hospital (BWH), a teaching affiliate of Harvard Medical School, is launching a five-year landmark study to examine the role of cocoa flavanols, plant-derived bioactives from the cacao bean, in helping people maintain cardiovascular health.
› Verified 7 days ago
Dr. Thomas Joseph Bice, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1969 Wellness Blvd, Monroe, NC 28110 Phone: 704-316-5775 Fax: 704-316-5815 | |
Rajiv Paudel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1550 Faulk St, Ste 3100, Monroe, NC 28112 Phone: 704-667-3410 | |
Charles H Hoover Iii, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1420 E Franklin St, Monroe, NC 28112 Phone: 704-289-8427 Fax: 704-283-5522 | |
Pascale Anglade, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1663 Campus Park Dr, Suite D, Monroe, NC 28112 Phone: 704-291-2488 Fax: 704-283-0160 | |
Pawan Damodhar Sarda, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 1640 E Roosevelt Blvd, Monroe, NC 28112 Phone: 704-226-0500 Fax: 704-226-0599 | |
Santhosh Reddy Devarapally, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1550 Faulk St, Ste 3100, Monroe, NC 28112 Phone: 704-667-3410 | |
Dr. James Wayne Roberts, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 1640 E Roosevelt Blvd, Monroe, NC 28112 Phone: 704-226-0500 Fax: 704-226-0599 |